Histologic distribution of borderline ovarian tumors worldwide: a systematic review
- PMID: 23346313
- PMCID: PMC3549507
- DOI: 10.3802/jgo.2013.24.1.44
Histologic distribution of borderline ovarian tumors worldwide: a systematic review
Abstract
Objective: The histologic types of borderline ovarian tumors (BOTs) exhibit striking differences in clinical behavior and prognosis. Yet, there is no information available on the histologic distribution of BOTs according to geographic region. The purpose of this study was to systematically review this issue worldwide.
Methods: A comprehensive search of the literature was conducted using electronic databases. Studies were eligible if BOTs were investigated and the histologic distribution of the data was shown. The studies were grouped by geographic region and totaled by country.
Results: Of 487 potentially relevant studies, 51 met our inclusion criteria, as follows: 8 studies from North America (2 countries); 26 studies from Europe (14 countries); 7 studies from the Middle East (3 countries); and 10 studies from East Asia (5 countries). The histologic distribution of BOTs was considerably different in different parts of the world, but follows specific patterns. In general, serous-type BOTs were the predominantly identified histology in North America, the Middle East, and Europe, while mucinous-type BOTs predominated in East Asia.
Conclusion: Significant geographic variation is evident among BOT histology in different parts of the world. More research is needed to understand this phenomenon.
Keywords: Borderline ovarian tumor; Histology; Low malignant potential; Systematic review.
Conflict of interest statement
No potential conflict of interest relevant to this article was reported.
Figures
References
-
- Taylor HC., Jr Malignant and semimalignant tumors of the ovary. Surg Gynecol Obstet. 1929;48:204–230.
-
- Cadron I, Leunen K, Van Gorp T, Amant F, Neven P, Vergote I. Management of borderline ovarian neoplasms. J Clin Oncol. 2007;25:2928–2937. - PubMed
-
- Koskas M, Uzan C, Gouy S, Pautier P, Lhomme C, Haie-Meder C, et al. Fertility determinants after conservative surgery for mucinous borderline tumours of the ovary (excluding peritoneal pseudomyxoma) Hum Reprod. 2011;26:808–814. - PubMed
-
- Uzan C, Kane A, Rey A, Gouy S, Duvillard P, Morice P. Outcomes after conservative treatment of advanced-stage serous borderline tumors of the ovary. Ann Oncol. 2010;21:55–60. - PubMed
-
- Silverberg SG, Bell DA, Kurman RJ, Seidman JD, Prat J, Ronnett BM, et al. Borderline ovarian tumors: key points and workshop summary. Hum Pathol. 2004;35:910–917. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous